Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Alvogen
Alvogen
Activities:
Regulatory
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Finance
Alvogen partners with Kinaxis on supply chain management
Kinaxis will help Alvogen effectively manage its product introduction and tender processes to determine project feasibility and impact across the supply chain
Distribution
Dipharma and Alvogen launch Diterin in South Korea
First drug commercially available for the treatment of hyperphenylalaninemia due to phenylketonuria
Finance
CVC Capital Partners leads consortium to acquire controlling stake in Alvogen
Consortium will provide funds to help Alvogen become a leading generics player worldwide
Finance
Alvogen acquires Dream Pharma of Korea for US$187m
Third significant acquisition for the company in the Asia-Pacific region since 2012
Manufacturing
Alvotech invests US$250m in biopharmaceuticals
Portfolio of biosimilar products to be marketed by sister company, Alvogen
Ingredients
Alvogen expands its operations in India
Clinical service and API sourcing capabilities established
Subscribe now